Ideal Acquisition Candidates Are Advanced-Stage With Good Data - IN3 Panel
This article was originally published in The Gray Sheet
Executive Summary
The most desirable acquisition candidates for established medical technology firms in the current economic climate are those in advanced stages of development with good comparative effectiveness data, according to panelists at the recent Investment In Innovation (IN3) Medical Device Summit
You may also be interested in...
Recession, Reform Efforts Put Pressure On MedTech Venture Funding Model
The recession, impending health care reform and the changing regulatory and reimbursement environment are putting pressure on the traditional medtech venture capital funding model, according to a 1report from consulting firm Ernst & Young
Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer
Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025. It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.
Xaira Launches With $1bn-Plus And End-To-End AI Strategy
ARCH and Foresite incubated the company and recruited Genentech R&D veteran Marc Tessier-Lavigne to keep data generation, machine learning research and drug development under one roof.